CAS 154607-00-8

Benzoic acid, 2-bromo-5-hydroxy-, methyl ester

Description:

Benzoic acid, 2-bromo-5-hydroxy-, methyl ester, with the CAS number 154607-00-8, is an organic compound characterized by its ester functional group, which is derived from benzoic acid. This compound features a bromine atom and a hydroxyl group positioned on the aromatic ring, specifically at the 2 and 5 positions, respectively. The presence of these substituents influences its chemical reactivity and physical properties. Typically, such compounds exhibit moderate solubility in organic solvents and limited solubility in water due to their hydrophobic aromatic structure. The hydroxyl group can participate in hydrogen bonding, which may enhance solubility in polar solvents. Additionally, the bromine atom can impart unique reactivity, making the compound useful in various synthetic applications, including as an intermediate in organic synthesis. Its potential applications may extend to pharmaceuticals, agrochemicals, or as a building block in the development of more complex molecules. Safety data should be consulted for handling and usage, as halogenated compounds can pose specific health and environmental risks.

Formula: C₈H₇BrO₃

2-broMo-5-hydroxybenzoic acid Methyl ester

CAS: 154607-00-8

Formula: C₈H₇BrO₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 231.0434

Ref: IN-DA00ABSR

Methyl 2-bromo-5-hydroxybenzoate

CAS: 154607-00-8

Methyl 2-bromo-5-hydroxybenzoate

Formula: C₈H₇BrO₃

Purity: ≥95%

Color and Shape: white solid

Molecular weight: 231.04g/mol

Ref: 54-OR400090

Methyl 2-bromo-5-hydroxybenzoate

CAS: 154607-00-8

Formula: C₈H₇BrO₃

Purity: 95%

Color and Shape: Crystalline,Powder

Molecular weight: 231.045

Ref: 10-F341704

2-Bromo-5-hydroxybenzoic acid methyl ester

CAS: 154607-00-8

2-Bromo-5-hydroxybenzoic acid methyl ester (2BB) is a phenoxy activator that activates the glucokinase activator. It has been shown to have a glucose lowering effect in both animal and human studies. 2BB is orally bioavailable and has an allosteric mode of action, which means it works by binding to the allosteric site on the enzyme's active site, thereby increasing its activity. It binds to the benzamide of glucokinase, which causes an increase in glucose uptake and utilization by cells. 2BB is being studied for use as an oral treatment for type II diabetes mellitus.

Formula: C₈H₇BrO₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 231.04 g/mol

Ref: 3D-FB66730